Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA6 | P23280 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CA9 | Q16790 | 5/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA4 | P22748 | 4/20 | 1.00 |
| ▸ | CA5A | P35218 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | CA3 | P07451 | 3/20 | 1.00 |
| ▸ | F13A1 | P00488 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Spermidine SCHEMBL8073115 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL288987 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3175232 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL431884 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL288605 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL5802297 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL15618 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL6253721 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4861043 | 0.97 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL573651 | 0.97 | LMNA (1.00) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060281820-A1 | Lfa-1 inhibitors and use thereof | SODA KUNIYASU | 2006-12-14 | — | — | US | claimed |
| US-20260125344-A1 | POLYURETHANE-ACETOACETATE COMPOUNDS | PPG INDUSTRIES OHIO, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12213503-B2 | Method of treating plant and method of making plant-based food or drink product | NICHIA CORPORATION (JP) | 2025-02-04 | — | — | US | disclosed |
| EP-4423059-A2 | POLYURETHANE-ACETOACETATE COMPOUNDS | PPG Industries Ohio, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-118201657-A | Cell adsorption material and cell adsorption column | 东丽株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-118159519-A | Polyurethane acetoacetate compounds | PPG工业俄亥俄公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-2023076835-A2 | POLYURETHANE-ACETOACETATE COMPOUNDS | PPG INDUSTRIES OHIO, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20220039437-A1 | METHOD OF TREATING PLANT AND METHOD OF MAKING PLANT-BASED FOOD OR DRINK PRODUCT | NICHIA CORPORATION (JP) | 2022-02-10 | — | — | US | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20100004342-A1 | LFA-1 Inhibitors and Use Thereof | SODA KUNIYASU | 2010-01-07 | — | — | US | disclosed |
| WO-2009093454-A1 | FOOD COMPOSITION, FEED COMPOSITION COMPRISING THE FOOD COMPOSITION, AND METHOD FOR FEEDING ANIMAL BY USING THE FEED COMPOSITION | JICHI MEDICAL UNIVERSITY (JP) | 2009-07-30 | — | — | WO | disclosed |
| US-20060281820-A1 | Lfa-1 inhibitors and use thereof | SODA KUNIYASU | 2006-12-14 | — | — | US | disclosed |
| US-4260683-A | Process for producing antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1981-04-07 | — | — | US | disclosed |
| US-4250170-A | AMINOGLYCOSIDE ANTIBIOTIC | BRISTOL-MYERS COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125344-A1 | POLYURETHANE-ACETOACETATE COMPOUNDS | HAT1, PUF60, GAR1 | CA12 801/4885CA6 810/4885CA7 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.